2/26
05:30 pm
mgnx
MacroGenics to Participate in Upcoming Investor Conferences
Neutral
Report
MacroGenics to Participate in Upcoming Investor Conferences
2/24
07:01 am
mgnx
MacroGenics (NASDAQ:MGNX) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..
High
Report
MacroGenics (NASDAQ:MGNX) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..
2/23
06:14 pm
mgnx
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
Low
Report
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
1/9
08:13 am
mgnx
Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer [Yahoo! Finance]
Neutral
Report
Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer [Yahoo! Finance]
1/3
05:42 am
mgnx
MacroGenics (NASDAQ:MGNX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Medium
Report
MacroGenics (NASDAQ:MGNX) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
12/18
07:02 pm
mgnx
December 2025 Penny Stocks Worth Watching [Yahoo! Finance]
Medium
Report
December 2025 Penny Stocks Worth Watching [Yahoo! Finance]
12/9
04:25 pm
mgnx
MacroGenics (NASDAQ:MGNX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
MacroGenics (NASDAQ:MGNX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.